Low rates of retained gastric contents were seen in endoscopy patients on GLP-1 receptor agonists ( RAs), a retrospective ...

Gilles Andrier, CEO of Givaudan discusses HY earnings, and outlines areas of growth within the business despite ongoing ...

The money will focus on a manufacturing plant in Virginia that will make the company's weight management and metabolic drugs ...

Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the ...

Company to Host Pre-Eminent Lap-Band® Surgeon Advocates For a Three-Day Seminar, August 1-3, 2025 ...

Coca-Cola is less exposed to the U.S. market’s weakness in snacks and soda, compared with other food and beverage companies.